Enovix (ENVX.US) Stock Rating 2026/2027: Buy – Stock Analysis

1.60
Share this analysis:

No analysts currently cover Enovix with a public price target. We add the price target automatically as soon as at least one analyst publishes a rating. Until then, use the technical analysis and the key figures below.

Analyst Ratings for Enovix stock in 2026: Buy

12 analysts cover Enovix. The majority is positive, with 66.7% recommending Buy, while 25% recommend Hold.

Consensus: Buy (4.25/5)
Strong Buy
8 (66.7%)
Hold
3 (25%)
Sell
1 (8.3%)
Strong Sell Sell Hold Buy Strong Buy
4.25 out of 5 based on 12 analysts

About Enovix – Electrical Equipment & Parts

Enovix Corporation designs, develops, and manufactures lithium-ion battery cells in the United States and internationally. It serves wearables and IoT, smartphone, computing, electrical vehicles, and original equipment manufacturers. The company was founded in 2006 and is headquartered in Fremont, California. Read more about the company

Key Figures for Enovix

$396M Market cap
$38.9M Revenue
Electrical Equipment & Parts Industry
- P/E
10.18 P/S
2.65 P/B
United States Listed on exchange
enovix.com Website

What kind of stock is Enovix?

Speculative stock

Enovix is classified as a speculative stock.

Score Overview for Enovix

💰 Value Score 15/100 (Very Low)
⭐ Quality Score 5/100 (Very Low)
🚀 Momentum Score 3/100 (Very Low)
📊 Total Score 7/100

⚠️ 4 red flags identified 3 critical

Our analysis has identified 4 potential risk factors in Enovix that investors should be aware of.

⚠️ Weak financial health: The Piotroski score is only 3/9 – the company shows signs of weakened profitability, liquidity or capital structure.
🚨 Weak balance sheet (elevated risk): Altman Z2 is -1.39 – the balance sheet is measurably weaker than average. This is a risk signal based on the numbers, not a bankruptcy prediction.
🚨 Negative return on equity: ROE is -67.6% – the company is generating a negative return for shareholders.
🚨 High short interest: 25.7% of the shares are sold short – many professional investors are betting on price declines.

📈 Valuation

The P/S ratio is 10.2 (high — the market pays a premium for the revenue). The P/B ratio is 2.6.

🏦 Financial Health

The Piotroski score is 3 out of 9 — weak financial health, be careful. Altman Z2 is -1.39 (weak balance sheet — elevated risk). The debt-to-equity ratio (D/E) is 112.6% — moderate debt.

🚀 Momentum & Short Interest

Short interest is 25.74% — very high, the market is skeptical.

Insider Trading in Enovix 2026: Buys and sells

In 2026, insiders at Enovix have made 20 transactions – split into 8 purchases and 12 sales. On a net basis, insiders took $1,699,707 out of the stock. Active insiders include Talluri Rajendra K, Rodgers Thurman J, Truong Kristina and others.

Last 3 Months: No trades

There has been no insider trading in the last 3 months.

All Transactions: Buys and sells

There are both insider purchases and sales, with no clear direction. This is normal for large companies, where management adjusts positions on an ongoing basis.

Across the last 20 transactions: 8 purchases and 12 sales. A net $1,699,707 out of the stock.

Latest purchase: Talluri Rajendra K bought 1,434 shares at $13.94 each on 2023-08-24. The stock has since fallen 88.5%.

Latest sale: Truong Kristina sold 2,296 shares at $7.31 each on 2026-01-01.

Who is buying: Talluri Rajendra K, Rodgers Thurman J.

Who is selling: Truong Kristina, Marathe Ajay, Reichow Gregory, Talluri Rajendra K, ATKINS BETSY S and others.

Latest Insider Trades in Enovix (2026)

The table shows the last 20 reported insider transactions in Enovix. Green rows are purchases, red rows are sales. The data is based on official filings.

Transaction date Name Type Number of shares Price per share (USD) Total amount (USD)
2026-01-01 Truong Kristina Sell 2,296 7.31 16,784
2025-10-08 Marathe Ajay Sell 18,614 13.00 241,982
2025-10-02 Marathe Ajay Sell 120,000 12.01 1,441,200
2025-05-02 Reichow Gregory Sell 8,129 6.57 53,408
2025-02-27 Talluri Rajendra K Sell 300,000 9.35 2,805,000
2024-12-03 ATKINS BETSY S Sell 75,000 9.73 729,750
2024-10-14 Chakravarthy Arthi Sell 35,000 13.00 455,000
2024-06-20 Reichow Gregory Sell 7,500 12.14 91,050
2024-04-14 Marathe Ajay Sell 4,954 7.31 36,214
2023-08-24 Talluri Rajendra K Buy 1,434 13.94 19,990

Who is buying and selling Enovix shares in 2026?

The following insiders have bought shares in Enovix: Talluri Rajendra K, Rodgers Thurman J. In total, $4,885,491 was bought across 8 transactions. The following insiders have sold shares: Truong Kristina, Marathe Ajay, Reichow Gregory, Talluri Rajendra K, ATKINS BETSY S and others. In total, $6,585,198 was sold across 12 transactions. Insider trades are legal transactions in which executives and board members buy or sell shares of their own company. These transactions are reported to the SEC and are publicly available.

Enovix Short Selling 2026: 25.7% Sold Short

Extremely shorted: 25.7% of the free float
Short % of free float
25.7%
Assessment
Extremely shorted
Short squeeze risk
Very High
Data source
EODHD
Reported about twice a month
The stock has an extremely high share of short selling. More than 20% of the freely traded shares are sold short, which is unusual and can point to great skepticism among institutional investors. The risk of a short squeeze on positive news is considerable.

What does this mean for you as an investor?
A short interest of 25.7% means that 25.7% of the freely traded shares in Enovix have been borrowed and sold by investors betting on falling prices. On positive surprises (e.g. a strong earnings report), short sellers can be forced to buy back shares quickly to close their positions, which can cause a short squeeze with sharp price gains in a short time.

Short interest comes from our data provider EODHD. The figure is reported about twice a month; we check it every trading day.
Short Interest Scale
0% 2% 5% 10% 20%+
Low Moderate High Very High Extreme
▲
25.7%

When Does Enovix Report Earnings?

The next earnings date for Enovix is not yet available. Check the company's investor calendar for more information.



Technical Analysis of Enovix 2026 – Signal: Strong Sell

Overall Technical Signal: Strong Sell

Based on trend analysis (SMA50/SMA200) and MACD trend (positive/negative on a daily + weekly basis). Updated November 14, 2026.

Trend Analysis of Enovix Corporation

Enovix Corporation is in a short-term downtrend. The price of $1.60 is 40.6% below the 20-day average ($2.70). Medium term, the picture is negative: the price is 42.5% below the 50-day average ($2.78). Long term, the stock is 67.4% below the 200-day average ($4.90), which signals a long-term downtrend.

Death Cross: The 50-day average (2.78) is below the 200-day average (4.90), which is a classic bearish signal for Enovix Corporation.

Is Enovix Corporation overbought or oversold?

Enovix Corporation has an RSI of 30.6. The stock sits in the lower part of the neutral zone, which points to weak momentum without being oversold. In the current downtrend, be careful about reading this as a buying opportunity.

MACD Analysis for Enovix Corporation

Daily MACD: MACD is negative (-0.190), which means the short-term trend is bearish (the 12-day EMA is below the 26-day EMA). MACD is below the signal line (-0.067) by 0.123, which confirms growing negative momentum in the downtrend.

Weekly MACD: MACD5 is negative (-0.975), which indicates a broader bearish long-term trend. MACD5 is above the signal line (-0.990) by 0.015, which suggests the negative long-term momentum is fading – a bigger trend reversal could be ahead.

Overall MACD assessment: Both the daily and weekly trend are bearish (MACD negative). However, momentum shows signs of improving on a weekly basis – a potential trend reversal could be ahead, but it is not confirmed yet.

Risk Profile for Enovix Corporation

Enovix Corporation has an annual standard deviation of 95.2%, which classifies the stock as Extremely speculative. Only risk-tolerant investors should consider this stock, because the price swings can be very large.

Overall Technical Conclusion for Enovix Corporation

Trend: Negative. The price trades below SMA50 and SMA200.

MACD trend (zero line): Daily bearish (-0.190). Weekly bearish (-0.975).

MACD momentum (signal): Daily falling. Weekly rising.

RSI: 30.6 – neutral.

Technical signal: Strong Sell

The price is in a downtrend (below SMA50/SMA200) and MACD is negative on both a daily and weekly basis. Avoid buying and consider closing existing positions.

Who Owns Enovix?

The three largest owners of Enovix are BlackRock Inc (7.5%), Vanguard Capital Management, LLC (3.9%) and Vanguard Portfolio Management, LLC (3.8%). The percentage is their share of the stock, as of Jun 30, 2026. Source: our data provider EODHD.

The 10 Largest Institutions

InstitutionStakeChange
BlackRock Inc7.51%+7.5%
Vanguard Capital Management, LLC3.87%+1.4%
Vanguard Portfolio Management, LLC3.82%+4.0%
UBS Group AG2.42%−8.0%
Geode Capital Management, LLC2.36%+6.4%
Electron Capital Partners, LLC2.18%+3.5%
State Street Corp2.15%+9.4%
Morgan Stanley - Brokerage Accounts1.58%+91.5%
Royal Bank of Canada1.14%+0.5%
Fred Alger Management, LLC0.96%+6.3%

As of Jun 30, 2026. "Change" is the change in shares held since the holder's previous report.

The 5 Largest Funds

FundStakeChange
Vanguard MStar Total Stk Mkt Idx Invest2.69%0.0%
iShares Russell 2000 ETF2.30%0.0%
Fidelity Small Cap Index1.04%+5.2%
Vanguard Small Cap Index0.96%−50.9%
iShares Russell 2000 Growth ETF0.84%−0.4%

As of Oct 30, 2026. A fund may be managed by one of the institutions above, so the two lists cannot be added together.

Frequently Asked Questions About Enovix stock in 2026

Should you buy Enovix stock now?
No, the technical signal for Enovix is currently Strong Sell. Enovix trades at $1.60 as of Nov 14, 2026. The technical analysis shows the following: MACD is negative (bearish trend) at -0.190 with falling momentum (signal: -0.067); RSI is at 30.6 (neutral zone); the stock is in a short-term downtrend (price below the 20-day average). The stock is in a broader downtrend (below SMA50/SMA200). Buying in a downtrend is generally not recommended. This is a technical observation based on current data, not investment advice.
What is the price target for Enovix stock?
There is currently no active analyst price target for Enovix.
Is Enovix a dividend stock?
No, Enovix does not currently pay a dividend to shareholders. The company reinvests its profits in growth instead of paying dividends.
What is the risk of Enovix stock?
Enovix is rated as a stock in the risk category Extremely speculative. the annual standard deviation is 95.2%, which classifies the stock as Extremely speculative.
Is Enovix overvalued?
Enovix has the following valuation ratios: a P/S ratio of 10.2, a P/B ratio of 2.6.
Is Enovix overbought?
No, Enovix is not overbought. RSI is at 30.6 (neutral zone). The technical indicators show: RSI is at 30.6 (neutral zone between 30-70), which signals neither overbought nor oversold. In addition, the price is 40.6% below the 20-day average (short-term downtrend). In addition, MACD is negative with falling momentum (bearish).
When is the next Enovix earnings report?
The date of the next earnings report for Enovix has not been published yet. Check the company's investor calendar for updates.
Is Enovix shorted?
Yes, Enovix is shorted with 25.7% of the free float sold short. This is an extremely high level of short selling, which points to great skepticism among institutional investors. The risk of a short squeeze on positive news or earnings is very high. The figure comes from our data provider EODHD, is reported about twice a month, and we check it every trading day.
Are insiders buying Enovix stock?
No, insiders are not buying Enovix shares – they are net sellers. Across the last 20 reported transactions, the split is 8 purchases and 12 sales, with a net 1,699,707 USD sold. Active sellers include Truong Kristina, Marathe Ajay, Reichow Gregory and others. Insider selling can have several explanations (e.g. planned 10b5-1 sales, portfolio diversification or taxes), but sustained selling by several insiders is worth watching closely.
Is Enovix a good stock?
Based on our total score, Enovix is rated as a disastrous stock with a total score of 7 out of 100. The stock scores very low on value, quality and momentum – it is among the worst in our database. The score is made up of Value: 15/100, Quality: 5/100, Momentum: 3/100. Whether now is the time to buy is a separate question: the technical signal is Strong Sell. Whether Enovix is a good investment depends on your time horizon, risk profile and portfolio. This is a data-driven observation, not investment advice.
What is the outlook for Enovix stock?
The outlook for Enovix based on current data: the stock is in a downtrend (below SMA50 and SMA200). Keep in mind that stock prices are affected by many factors, including earnings reports, the economy and market sentiment. Past returns are no guarantee of future returns.
Why is Enovix stock falling?
Enovix is falling right now. The technical indicators show: the price is 40.6% below the 20-day average; MACD is negative with falling momentum (bearish signal); short interest is 25.7% (high – many are betting on a decline); insiders have mostly been selling the stock recently. For the latest context, see our technical analysis and insider section above.
How high can Enovix go?
There is currently no active analyst price target for Enovix. The stock has traded between $1.53 and $9.19 over the last 52 weeks. The price is 82.6% below the 52-week high, which can indicate potential if the underlying fundamentals are intact. Keep in mind that price targets are estimates, not guarantees. Actual price moves depend on earnings, market conditions and unexpected events.
How low can Enovix fall?
The stock has traded as low as $1.53 over the last 52 weeks — that is 4.4% below the current price of $1.60. The biggest decline (drawdown) in the same period was 83.4% from high to low. Within a year, the price typically swings about ±95.2% (standard deviation — a measure of price swings). A difficult year could therefore mean a further decline of that size. Remember: past price swings are no guarantee for the future — a stock can fall further than the last 52 weeks suggest, especially on profit warnings, sector crises or a market crash. Use stop-loss orders and spread your portfolio to limit losses in single stocks.
What does Enovix do?
Enovix Corporation designs, develops, and manufactures lithium-ion battery cells in the United States and internationally. It serves wearables and IoT, smartphone, computing, electrical vehicles, and original equipment manufacturers. The company was founded in 2006 and is head... The company belongs to the Industrials sector, more specifically the Electrical Equipment & Parts industry, is headquartered in United States, and is traded on the USA Stocks. See the key figures, earnings history and price development above to evaluate Enovix as an investment.
Did Enovix raise or lower its guidance?
Over the last 60 days we have not registered a guidance raise or cut from Enovix. The company can still adjust its guidance at quarterly reports or between reports — see the earnings history above.
Is Enovix making money or losing money?
We have no current profitability data for Enovix. See the latest report in the earnings history above.
Can Enovix go bankrupt?
The bankruptcy risk of Enovix is rated as elevated. Altman Z2 (a model for assessing financial distress) is -1.39 — that places the company in the weak zone. This is a probability based on the numbers, not a verdict — bankruptcy is not imminent. But the balance sheet is measurably weaker than average, so watch the debt, liquidity and possible capital raises. The Piotroski score (financial health 0-9, higher is better) is 3 — which is weak. Debt relative to equity is 113% (moderate). Remember: models like Altman Z2 are statistical — unexpected shocks (fraud, a sector collapse, lawsuits) can always happen. Spread your portfolio.
Does Enovix have a lot of debt?
Enovix has moderate debt relative to equity. The debt-to-equity ratio (D/E — interest-bearing debt to equity) is 113%. For the industrials sector, 100-200% counts as a typical level. Industrial companies often sit at 100-200% because of heavy production assets and long order books. Note: D/E levels are highly sector-specific — a bank at 300% debt is normal, a tech stock at 300% is extremely leveraged. Always compare with similar companies in the same sector.

Other Stocks in Industrials

Compare Enovix with other stocks in the industrials sector. Click a stock to see its technical analysis, insider trading and key figures.

See all 138 stocks in the Industrials sector